Next report date
Report period
H1 2024
EPS estimate
0.88HKD
Revenue estimate
2.29 BHKD
1.65HKD
1.60 BHKD
3.89 BHKD
386.29 M
About GIANT BIOGENE HLDG CO. LTD
Sector
Industry
CEO
Jian Ya Yan
Website
Headquarters
Xi'an
Employees (FY)
1.16 K
Founded
2000
FIGI
BBG01B6JG2Y7
Giant Biogene Holding Co. Ltd. engages in research, development, manufacture, and sale of bioactive material-based beauty and health products. The company was founded by Jian Ya Yan and Dai Di Fan on May 2000 and is headquartered in Xi'an, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2367 is 48.05 HKD — it has increased by 0.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GIANT BIOGENE HLDG CO. LTD stocks are traded under the ticker 2367.
GIANT BIOGENE HLDG CO. LTD is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
2367 stock is 2.77% volatile and has beta coefficient of 0.77. Check out the list of the most volatile stocks — is GIANT BIOGENE HLDG CO. LTD there?
2367 earnings for the last quarter are 0.71 HKD per share, whereas the estimation was 0.63 HKD resulting in a 13.79% surprise. The estimated earnings for the next quarter are 0.84 HKD per share. See more details about GIANT BIOGENE HLDG CO. LTD earnings.
GIANT BIOGENE HLDG CO. LTD revenue for the last quarter amounts to 1.74 B HKD despite the estimated figure of 1.59 B HKD. In the next quarter revenue is expected to reach 2.03 B HKD.
Yes, you can track GIANT BIOGENE HLDG CO. LTD financials in yearly and quarterly reports right on TradingView.
2367 stock has risen by 1.16% compared to the previous week, the month change is a 12.93% rise, over the last year GIANT BIOGENE HLDG CO. LTD has showed a 22.58% increase.
2367 net income for the last quarter is 847.86 M HKD, while the quarter before that showed 754.28 M HKD of net income which accounts for 12.41% change. Track more GIANT BIOGENE HLDG CO. LTD financial stats to get the full picture.
Today GIANT BIOGENE HLDG CO. LTD has the market capitalization of 46.90 B, it has increased by 9.30% over the last week.
Like other stocks, 2367 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GIANT BIOGENE HLDG CO. LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 1.16 K employees. See our rating of the largest employees — is GIANT BIOGENE HLDG CO. LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GIANT BIOGENE HLDG CO. LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GIANT BIOGENE HLDG CO. LTD stock shows the strong buy signal. See more of GIANT BIOGENE HLDG CO. LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GIANT BIOGENE HLDG CO. LTD future price: according to them, 2367 price has a max estimate of 59.02 HKD and a min estimate of 47.94 HKD. Read a more detailed GIANT BIOGENE HLDG CO. LTD forecast: see what analysts think of GIANT BIOGENE HLDG CO. LTD and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GIANT BIOGENE HLDG CO. LTD EBITDA is 1.82 B HKD, and current EBITDA margin is 46.70%. See more stats in GIANT BIOGENE HLDG CO. LTD financial statements.